نتائج البحث - "ISCHEMIC postconditioning"

1

Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST-elevation myocardial infarction: the randomized LIPSIA CONDITIONING trial

المؤلفون: Enno Boudriot, Thomas Stiermaier, Sandra Erbs, Ingo Eitel, Georg Fuernau, Norman Mangner, Karl Philipp Rommel, Axel Linke, Holger Thiele, Gerhard Schuler, Marcus Sandri, P. Lurz, Steffen Desch, Meinhard Mende

المصدر: European Heart Journal. 36:3049-3057

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b5806c3a0113261812b6752dc86b4bbTest
https://doi.org/10.1093/eurheartj/ehv463Test

2

Post-ischaemic silencing of p66Shcreduces ischaemia/reperfusion brain injury and its expression correlates to clinical outcome in stroke

المساهمون: University of Zurich, Camici, G G

المصدر: EUROPEAN HEART JOURNAL
European Heart Journal, 36
European Heart Journal

مصطلحات موضوعية: Male, Small interfering RNA, Pathology, Gene Expression, Free radicals, 030204 cardiovascular system & hematology, Ischaemia, 10052 Institute of Physiology, 0302 clinical medicine, Claudin-5, RNA, Small Interfering, Ischemic Postconditioning, Stroke, Cells, Cultured, Aged, 80 and over, Infarction, Middle Cerebral Artery, 11359 Institute for Regenerative Medicine (IREM), Human brain, Middle Aged, 10081 Institute of Veterinary Physiology, Treatment Outcome, medicine.anatomical_structure, Blood-Brain Barrier, 10076 Center for Integrative Human Physiology, Gene Knockdown Techniques, Reperfusion Injury, 10209 Clinic for Cardiology, Cardiology, Female, medicine.symptom, Cardiology and Cardiovascular Medicine, hormones, hormone substitutes, and hormone antagonists, medicine.medical_specialty, Src Homology 2 Domain-Containing, Transforming Protein 1, Ischemia, 610 Medicine & health, 2705 Cardiology and Cardiovascular Medicine, Lesion, 03 medical and health sciences, Reperfusion therapy, Internal medicine, medicine, Animals, Humans, 10237 Institute of Biomedical Engineering, Gene Silencing, RNA, Messenger, Endothelium, Aged, Analysis of Variance, business.industry, Microcirculation, Endothelial Cells, Hypoxia (medical), medicine.disease, Mice, Inbred C57BL, Shc Signaling Adaptor Proteins, Reperfusion, Brain Injuries, Case-Control Studies, 570 Life sciences, biology, Reactive Oxygen Species, business, Reperfusion injury, 030217 neurology & neurosurgery

وصف الملف: 2015_ Eur Heart Journal.pdf - application/pdf; 2015- EHJ_manuscript.pdf - application/pdf; supplemental%20material.pdf - application/pdf; figures%20and%20tables%2C%20Spescha%202015.pdf - application/pdf; application/application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f64d83ba711f92c68667d2853a11691Test
https://doi.org/10.1093/eurheartj/ehv140Test

3

Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote Ischaemic Preconditioning with Postconditioning Outcome Trial

المؤلفون: Eun-Ho Lee, Hyun Joo Kim, Ji Yeon Sim, Ji Hyun Chin, Jae-Hyon Bahk, Dae-Kee Choi, Deok Man Hong, Jeong Jin Min, In Cheol Choi, Yunseok Jeon

المصدر: European Heart Journal. 35:176-183

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Adolescent, Critical Care, Heart Diseases, law.invention, Young Adult, Coronary artery bypass surgery, Postoperative Complications, law, Internal medicine, medicine, Cardiopulmonary bypass, Clinical endpoint, Humans, Hospital Mortality, Prospective Studies, Myocardial infarction, Intraoperative Complications, Ischemic Postconditioning, Stroke, Aged, Aged, 80 and over, business.industry, Cardiogenic shock, Length of Stay, Middle Aged, Thoracic Surgical Procedures, medicine.disease, Cardiac surgery, Treatment Outcome, Ischemic Preconditioning, Myocardial, Cardiology, Ischemic preconditioning, Female, Cardiology and Cardiovascular Medicine, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94fc18b052991fd862508be16ab3eb26Test
https://doi.org/10.1093/eurheartj/eht346Test

4

No post-conditioning in the human heart with thrombolysis in myocardial infarction flow 2-3 on admission

المساهمون: Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hospices Civils de Lyon (HCL), RMN et optique : De la mesure au biomarqueur, Centre de Recherche en Acquisition et Traitement de l'Image pour la Santé (CREATIS), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Hospices Civils de Lyon (HCL)-Université Jean Monnet [Saint-Étienne] (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Hospices Civils de Lyon (HCL)-Université Jean Monnet [Saint-Étienne] (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp), Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Institut National de la Recherche Agronomique (INRA), Université Jean Monnet [Saint-Étienne] (UJM)-Hospices Civils de Lyon (HCL)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Jean Monnet [Saint-Étienne] (UJM)-Hospices Civils de Lyon (HCL)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)

المصدر: Eur Heart J
Eur Heart J, 2014, 35 (25), pp.1675-82. ⟨10.1093/eurheartj/ehu054⟩
European Heart Journal
European Heart Journal, Oxford University Press (OUP): Policy B, 2014, 35 (25), pp.1675-82. ⟨10.1093/eurheartj/ehu054⟩

مصطلحات موضوعية: Adult, Male, Acute coronary syndrome, medicine.medical_specialty, medicine.medical_treatment, Troponin/metabolism, [SDV]Life Sciences [q-bio], Myocardial Infarction, Infarction, Myocardial Reperfusion, Biomarkers/metabolism, Young Adult, Reperfusion therapy, Fibrinolytic Agents, Angioplasty, Internal medicine, Coronary Occlusion/pathology/therapy, medicine, Humans, Single-Blind Method, Myocardial infarction, cardiovascular diseases, Ischemic Postconditioning, Creatine Kinase, ComputingMilieux_MISCELLANEOUS, Aged, business.industry, Fibrinolytic Agents/therapeutic use, Thrombolysis, Middle Aged, medicine.disease, Troponin, 3. Good health, Myocardial Reperfusion/*methods, Treatment Outcome, Coronary Occlusion, Coronary occlusion, Cardiology, Ischemic Postconditioning/*methods, Female, Stents, Creatine Kinase/metabolism, Cardiology and Cardiovascular Medicine, business, TIMI, Biomarkers, Myocardial Infarction/pathology/*therapy